NCM Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $983K | Sell |
21,226
-100
| -0.5% | -$4.63K | 0.4% | 62 |
|
2025
Q1 | $1.3M | Sell |
21,326
-300
| -1% | -$18.3K | 0.58% | 42 |
|
2024
Q4 | $1.22M | Buy |
21,626
+238
| +1% | +$13.5K | 0.55% | 44 |
|
2024
Q3 | $1.11M | Sell |
21,388
-200
| -0.9% | -$10.3K | 0.53% | 45 |
|
2024
Q2 | $897K | Buy |
21,588
+6,700
| +45% | +$278K | 0.47% | 50 |
|
2024
Q1 | $807K | Sell |
14,888
-1,034
| -6% | -$56.1K | 0.45% | 58 |
|
2023
Q4 | $817K | Buy |
15,922
+700
| +5% | +$35.9K | 0.5% | 58 |
|
2023
Q3 | $883K | Sell |
15,222
-85
| -0.6% | -$4.93K | 0.63% | 44 |
|
2023
Q2 | $979K | Hold |
15,307
| – | – | 0.68% | 42 |
|
2023
Q1 | $1.06M | Hold |
15,307
| – | – | 0.79% | 33 |
|
2022
Q4 | $1.1M | Hold |
15,307
| – | – | 0.73% | 37 |
|
2022
Q3 | $1.09M | Sell |
15,307
-200
| -1% | -$14.2K | 0.82% | 34 |
|
2022
Q2 | $1.19M | Hold |
15,507
| – | – | 0.84% | 40 |
|
2022
Q1 | $1.13M | Sell |
15,507
-500
| -3% | -$36.5K | 0.71% | 40 |
|
2021
Q4 | $998K | Buy |
+16,007
| New | +$998K | 0.89% | 32 |
|